Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs YieldMax AMZN Option Income Strategy ETF (AMZY) Price & Performance

Amylx Pharmaceuticals IncTrade
YieldMax AMZN Option Income Strategy ETFTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs YieldMax AMZN Option Income Strategy ETF — how do they compare? Amylx Pharmaceuticals Inc trades at $23.75 (market cap $2.64B), while YieldMax AMZN Option Income Strategy ETF trades at $11.32. The key difference: Amylx Pharmaceuticals Inc is trading nearer its 52-week high, YieldMax AMZN Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.

AMLXAMZY
Market Cap
$2.64B
Sector
HealthIncome / Options Overlay
52-Week High
$24.19$15.75
52-Week Low
$7.82$9.98
Enterprise Value
$2.39B

Returns comparison

Trailing returns across standard periods

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About YieldMax AMZN Option Income Strategy ETF

AMZY is an actively managed ETF that seeks to generate monthly income by selling call options on Amazon (AMZN) stock. It aims to provide high yield while maintaining exposure to the price movements of the e-commerce giant.

Read more on AMZY